Funding for this research was provided by:
German Federal Ministry of Education and Research (BMBF)
TÜFF Habilitation Program for Women of the Faculty of Medicine Tübingen, Germany (grant no° 2521-0-0)
Text and Data Mining valid from 2019-07-12
Received: 8 February 2019
Accepted: 27 June 2019
First Online: 12 July 2019
Ethics approval and consent to participate
: Written consent for the participation in the study was obtained from all patients and informed consent was also given according to the Gene Diagnostic Law in Germany. Ethics committee of the Ärztekammer Baden-Württemberg and local ethics committee of the Eberhard Karls University approved this study (approval numbers F-2016-010 and 827/2018BO2).
: Not applicable.
: AF served as consultant to Roche, Novartis, MSD, Pierre-Fabre; received travel support from Roche, Novartis, BMS, Pierre-Fabre, received speaker fees from Cegat, Roche, Novartis, BMS, MSD. TA received travel support from Novartis. TE served as consultant to Roche, Novartis, MSD, BMS, Pierre-Fabre; received speaker fees from Roche, Novartis, BMS, MSD. CG reports grants and personal fees from Novartis, BMS, Roche, personal fees from MSD. Personal fees from Amgen, Philogen, LEO, Incyte, outside the submitted work. DD received travel support from BMS. No competing interests were declared by the other authors.